Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome.
Semin Nephrol. 2004 May;24(3):179-96
Pathogenesis of IgA nephropathy.
Semin Nephrol. 2004 May;24(3):197-217
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.
Semin Nephrol. 2004 May;24(3):218-24
The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy.
Semin Nephrol. 2004 May;24(3):225-43
Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy.
Semin Nephrol. 2004 May;24(3):244-55
Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
Semin Nephrol. 2004 May;24(3):256-68
Pediatric IgA nephropathies: clinical aspects and therapeutic approaches.
Semin Nephrol. 2004 May;24(3):269-86
Recurrent IgA nephropathy after renal transplantation.
Semin Nephrol. 2004 May;24(3):287-91
Osler was right.
Semin Nephrol. 2004 May;24(3):292-6